LERK‑3 (Ephrin‑A3/EFNA3) Structure, Signaling, and Disease Relevance

LERK‑3 (Ephrin‑A3/EFNA3) Structure, Signaling, and Disease Relevance

Liquid error (snippets/article-card line 119): The format option '%d %b, %Y' is not a supported format.AntBio

ANT BIO Official Literature Interpretation: LERK‑3 (Ephrin‑A3/EFNA3) Structure, Signaling, and Disease Relevance Exclusive Analysis Powered by ANT BIO PTE. LTD. 1. Literature Information This literature systematically dissects the molecular architecture,...

10 Apr 2026AntBio

LERK‑3 (Ephrin‑A3/EFNA3) Structure, Signaling, and Disease Relevance

ANT BIO Official Literature Interpretation: LERK‑3 (Ephrin‑A3/EFNA3) Structure, Signaling, and Disease Relevance Exclusive Analysis Powered by ANT BIO PTE. LTD. 1. Literature Information This literature systematically dissects the molecular architecture,...

Read More
Behind the First KRAS-Targeted Drug: Breaking the “Undruggable” Myth of Ras Family Proteins

Behind the First KRAS-Targeted Drug: Breaking the “Undruggable” Myth of Ras F...

Liquid error (snippets/article-card line 119): The format option '%d %b, %Y' is not a supported format.AntBio

ANTI BIO PTE. LTD. Official Article Behind the First KRAS-Targeted Drug: Breaking the “Undruggable” Myth of Ras Family Proteins 1. Literature Information This literature systematically elucidates the structural characteristics, functional...

10 Apr 2026AntBio

Behind the First KRAS-Targeted Drug: Breaking the “Undruggable” Myth of Ras F...

ANTI BIO PTE. LTD. Official Article Behind the First KRAS-Targeted Drug: Breaking the “Undruggable” Myth of Ras Family Proteins 1. Literature Information This literature systematically elucidates the structural characteristics, functional...

Read More
Bias Modulation: A Novel Strategy to Unlock the Therapeut Potential of IL-2 in Cancer Immunotherapy

Bias Modulation: A Novel Strategy to Unlock the Therapeut Potential of IL-2 i...

Liquid error (snippets/article-card line 119): The format option '%d %b, %Y' is not a supported format.AntBio

Bias Modulation: A Novel Strategy to Unlock the Therapeut Potential of IL-2 in Cancer Immunotherapy ANT BIO Exclusive Literature Interpretation Article 1. Literature Information This literature focuses on interleukin-2 (IL-2)...

10 Apr 2026AntBio

Bias Modulation: A Novel Strategy to Unlock the Therapeut Potential of IL-2 i...

Bias Modulation: A Novel Strategy to Unlock the Therapeut Potential of IL-2 in Cancer Immunotherapy ANT BIO Exclusive Literature Interpretation Article 1. Literature Information This literature focuses on interleukin-2 (IL-2)...

Read More
His-Tag Technology: Core Tools for Protein Purification & Research Literature Analysis Edition

His-Tag Technology: Core Tools for Protein Purification & Research Literature...

Liquid error (snippets/article-card line 119): The format option '%d %b, %Y' is not a supported format.AntBio

ANT BIO Official Article: His-Tag Technology: Core Tools for Protein Purification & Research Literature Analysis Edition 1. Literature Information This literature focuses on the histidine tag (His‑tag) as a universal...

10 Apr 2026AntBio

His-Tag Technology: Core Tools for Protein Purification & Research Literature...

ANT BIO Official Article: His-Tag Technology: Core Tools for Protein Purification & Research Literature Analysis Edition 1. Literature Information This literature focuses on the histidine tag (His‑tag) as a universal...

Read More
FGFR3 K650M Mutation – Mechanisms, Pathogenicity, and Targeted Therapeutic Development Literature Overview

FGFR3 K650M Mutation – Mechanisms, Pathogenicity, and Targeted Therapeutic De...

Liquid error (snippets/article-card line 119): The format option '%d %b, %Y' is not a supported format.AntBio

ANT BIO Official Literature Review: FGFR3 K650M Mutation – Mechanisms, Pathogenicity, and Targeted Therapeutic Development Literature Overview This review systematically summarizes the structural and functional characteristics of FGFR3, the biological...

10 Apr 2026AntBio

FGFR3 K650M Mutation – Mechanisms, Pathogenicity, and Targeted Therapeutic De...

ANT BIO Official Literature Review: FGFR3 K650M Mutation – Mechanisms, Pathogenicity, and Targeted Therapeutic Development Literature Overview This review systematically summarizes the structural and functional characteristics of FGFR3, the biological...

Read More
FGFR3 G697C Mutation: Mechanisms, Disease Links and Therapeutic Prospects

FGFR3 G697C Mutation: Mechanisms, Disease Links and Therapeutic Prospects

Liquid error (snippets/article-card line 119): The format option '%d %b, %Y' is not a supported format.AntBio

Research Progress on the FGFR3 G697C Mutation: Mechanisms, Disease Links and Therapeutic Prospects 1. Concept Fibroblast Growth Factor Receptor 3 (FGFR3) is a transmembrane receptor tyrosine kinase that regulates cell...

10 Apr 2026AntBio

FGFR3 G697C Mutation: Mechanisms, Disease Links and Therapeutic Prospects

Research Progress on the FGFR3 G697C Mutation: Mechanisms, Disease Links and Therapeutic Prospects 1. Concept Fibroblast Growth Factor Receptor 3 (FGFR3) is a transmembrane receptor tyrosine kinase that regulates cell...

Read More